My brief observation is that the cost-benefit analysis of investments in vaccine production and development were not correct. We have, as you noted, a $1-billion investment by the Canadian government. The losses to the Canadian economy are orders of magnitude larger. You have to wonder if more money had been spent and invested along the entire vaccine supply chain, whether the result would have been different.
In this regard, the British experience, where they spent over 10 billion pounds doing this, gives you some sense of the type of money involved. I would argue that the British experience showed there was a very close partnership between industry and government, and that does not appear to be the case in Canada.